AMP-X-0079
PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit
Updated: 04/10/2020
Pipeline Type
New Drugs in Development
Phase Of Development
Preclinical
Sponsors and Collaborators
AurimMed Pharma, Inc., Epilepsy Foundation (EF)
Mechanism of Action
N/A
Mechanism Description
N/A
Populations Tested In
N/A
Other Resources
Special FDA Designation
Nonprofit or Government Support
Nonprofit
Nonprofit or Government Support Description
Epilepsy Foundation - SEAL 2013
Previous Presentations
Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
2015 Eilat
Location of Clinical Trials
N/A
Clinical Trial link